On July 27, 2023, the 75th American Association for Clinical Chemistry (AACC) came to a successful conclusion at the Anaheim Convention Center in California, USA. The three-day event showcased the latest technological achievements and diagnostic equipment in the global clinical testing field, attracting over 10,000 international medical professionals from more than 100 countries.
On the eve of the expo's opening, the AACC announced its official name change to the "Association for Diagnostics and Laboratory Medicine (ADLM)" worldwide. This change aims to more accurately reflect the diversity of its members, encompassing all professionals engaged in clinical laboratory-related work and clinical chemists.
Over the years, Autobio has been actively engaged on this influential global stage of clinical testing, engaging in in-depth exchanges with international experts and scholars, absorbing advanced concepts, and sharing developments in diagnostic technology. During this expo, Autobio exhibited several strategic products, including the AutoLumo A1860- fully Automatic Luminescence Immunoassay Analyzer, Autof MS 1000, blood culture system BC60,and AutoMolec 3000-automated nucleic acid purification and real-time PCR system. We also shared more innovative achievements in the field of diagnostics with attendees.
Autobio's booth attracted significant attention from the attendees, and the company's international business representatives actively interacted and exchanged with visitors, explaining product features and introducing the company's current developments.
During the exhibition, Autobio also invited international partners to visit its research and development center in the United States and organized partnership meeting. During the meeting, Mr. Fu Guangyu, Executive Vice President of Autobio, expressed gratitude to the international partners for their trust and support over the years. He emphasized Autobio's commitment to research and development by establishing a technical R&D system centered in Zhengzhou, with branches in Beijing, Shanghai, Shenzhen, Suzhou, and the United States. The U.S. research and development center serves as one of the company's bases for developing new projects and platforms and is an essential part of Autobio's international development.